|
2023 Conference Publication Dietary resistant starch alters gut microbiota, microbially produced metabolites and albuminuria in diabetic miceSnelson, M., Tan, S. M., Kumar, V., Woodruff, T. and Coughlan, M. T. (2023). Dietary resistant starch alters gut microbiota, microbially produced metabolites and albuminuria in diabetic mice. 46th Annual Scientific Meeting of the Nutrition Society of Australia, Perth, WA, Australia, 29 November – 2 December 2022. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0029665123001921 |
|
2022 Conference Publication Identification of potent small peptides targeting human C3a receptorDeerain, Nick, Kumar, Vinod, Clark, Richard and Woodruff, Trent (2022). Identification of potent small peptides targeting human C3a receptor. ICW – 2021 Virtual Workshop of the International Complement Society (ICS), Virtual, 7-10 December 2021. Oxford, United Kingdom: Elsevier. |
|
2021 Conference Publication Stimulating the Activity of NEP and ACE2: A Unique Approach to Prevent DementiaTran, Shirley, Woodruff, Trent, Kumar, Vinod, Smith, A. Ian, Rajapakse, Niwanthi and Kuruppu, Sanjaya (2021). Stimulating the Activity of NEP and ACE2: A Unique Approach to Prevent Dementia. Experimental Biology Meeting EB 2021, Online, 27–30 April 2022. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1096/fasebj.2021.35.s1.01628 |
|
2016 Conference Publication Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1Gordon, Richard, Albornoz, Eduardo A., Kumar, Vinod, Zhou, Kiane, Garin-Michaud, Ashoka, Mantavani, Susanna, Kanthasamy, Anumantha G. and Woodruff, Trent M. (2016). Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1. The XXVI International Complement Workshop (ICW), Kanazawa, Japan, 4-8 September 2016. Muenchen, Germany: Elsevier. doi: 10.1016/j.imbio.2016.06.146 |
|
2015 Conference Publication Blood brain barrier impairment alters the pharmacokinetic properties of the complement C5aR1 antagonist PMX205 in mouse models of neurodegenerationKumar, Vinod, Lee, John, Noakes, Peter and Woodruff, Trent (2015). Blood brain barrier impairment alters the pharmacokinetic properties of the complement C5aR1 antagonist PMX205 in mouse models of neurodegeneration. 8th International Conference on Complement Therapeutics, Chania, Crete, Greece, 1-6 January 2015. |
|
2013 Conference Publication Behavioural and pathological phenotyping of the C57BL/6J BACHD transgenic mouse model of Huntington’s diseaseMantovani, S., Li, R., Gordon, R., Kumar, V., Taylor, S. and Woodruff, T. M. (2013). Behavioural and pathological phenotyping of the C57BL/6J BACHD transgenic mouse model of Huntington’s disease. World Congress on Huntington’s disease, Rio de Janeiro, Brazil, 15-18 September 2013. Amsterdam, Netherlands: I O S Press. |
